e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
Respiratory syncytial virus infections throughout life
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development of RSV vaccines: where are we?
N. Scheltema (Utrecht, Netherlands)
Source:
International Congress 2019 – Respiratory syncytial virus infections throughout life
Session:
Respiratory syncytial virus infections throughout life
Session type:
Symposium
Number:
5311
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Scheltema (Utrecht, Netherlands). Development of RSV vaccines: where are we?. International Congress 2019 – Respiratory syncytial virus infections throughout life
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Development of RSV antiviral treatment: where are we?
Source: International Congress 2019 – Respiratory syncytial virus infections throughout life
Year: 2019
Seasonal influenza vaccine effectiveness in people with asthma: A systematic review
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
New treatments for RSV and other viruses, including update on vaccines
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Understanding new vaccines for SARS-CoV-2 and their regulation
Source: ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation
Year: 2021
Ebola: progress with vaccines
Source: International Congress 2015 – Pandemics and emerging infections
Year: 2015
Influenza surveillance and vaccination: new developments
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017
COVID-19 vaccination and more
Source: ERS webinar 2021: COVID-19 vaccination and more
Year: 2021
Novel intradermal influenza vaccine: phase 3 data in targeted adult populations
Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Year: 2008
Immunology underpinning vaccine strategy: what is the risk of reinfection?
Source: Virtual Congress 2020 – Management prevention
Year: 2020
Pneumococcal vaccine: when, what, how and to whom
Source: International Congress 2014 – MS06 What's new in pneumococcal vaccination?
Year: 2014
COVID-19 mRNA vaccines: a step forward from traditional vaccines?
Source: Virtual Congress 2021 – Scientific year in review
Year: 2021
Medical staff attitude to vaccination against an influenza virus
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Should pneumococcal vaccines be used to prevent LRTI?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Rhinovirus vaccination: the case in favour
Source: Eur Respir J 2011; 37: 3-4
Year: 2011
Influenza: vaccination and treatment
Source: Eur Respir J 2001; 17: 1282-1293
Year: 2001
Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making
Source: Eur Respir J 2006; 27: 661-663
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept